1-1916468-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_138705.4(CALML6):c.106A>G(p.Lys36Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138705.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CALML6 | NM_138705.4 | c.106A>G | p.Lys36Glu | missense_variant | 3/6 | ENST00000307786.8 | NP_619650.2 | |
CALML6 | NM_001330313.2 | c.55A>G | p.Lys19Glu | missense_variant | 2/5 | NP_001317242.1 | ||
CALML6 | XM_005244729.4 | c.172A>G | p.Lys58Glu | missense_variant | 3/6 | XP_005244786.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CALML6 | ENST00000307786.8 | c.106A>G | p.Lys36Glu | missense_variant | 3/6 | 1 | NM_138705.4 | ENSP00000304643.3 | ||
CALML6 | ENST00000378604.3 | c.55A>G | p.Lys19Glu | missense_variant | 2/5 | 3 | ENSP00000367867.3 | |||
CALML6 | ENST00000482402.1 | n.1203A>G | non_coding_transcript_exon_variant | 1/3 | 2 | |||||
CALML6 | ENST00000462293.1 | n.328-284A>G | intron_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 39
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 17, 2023 | The c.106A>G (p.K36E) alteration is located in exon 3 (coding exon 3) of the CALML6 gene. This alteration results from a A to G substitution at nucleotide position 106, causing the lysine (K) at amino acid position 36 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.